The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy.
Saved in:
| Title: | The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy. |
|---|---|
| Authors: | Bornes L; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Winden LJ; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts VCM; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Bruijn B; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium., Azarang L; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lanfermeijer M; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Caruso M; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium., Proost N; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Boeije M; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lohuis JO; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Belthier G; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Noguera Delgado E; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Gruil N; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Ven M; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Menezes R; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kok M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn S; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Utrecht University Medical Center, Utrecht, the Netherlands., Broeks A; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum HH; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Scheele CLGJ; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium. colinda.scheele@kuleuven.be., van Rheenen J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. j.v.rheenen@nki.nl. |
| Source: | Nature [Nature] 2025 Jan; Vol. 637 (8044), pp. 195-204. Date of Electronic Publication: 2024 Dec 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39633046 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bornes+L%22">Bornes L</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Winden+LJ%22">van Winden LJ</searchLink>; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Geurts+VCM%22">Geurts VCM</searchLink>; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Bruijn+B%22">de Bruijn B</searchLink>; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Azarang+L%22">Azarang L</searchLink>; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lanfermeijer+M%22">Lanfermeijer M</searchLink>; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Caruso+M%22">Caruso M</searchLink>; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Proost+N%22">Proost N</searchLink>; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boeije+M%22">Boeije M</searchLink>; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lohuis+JO%22">Lohuis JO</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Belthier+G%22">Belthier G</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Noguera+Delgado+E%22">Noguera Delgado E</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Gruil+N%22">de Gruil N</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kroep+JR%22">Kroep JR</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Ven+M%22">van de Ven M</searchLink>; Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Menezes+R%22">Menezes R</searchLink>; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Wesseling+J%22">Wesseling J</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kok+M%22">Kok M</searchLink>; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Linn+S%22">Linn S</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Utrecht University Medical Center, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Broeks+A%22">Broeks A</searchLink>; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Rossum+HH%22">van Rossum HH</searchLink>; Laboratory of Clinical Chemistry and Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Scheele+CLGJ%22">Scheele CLGJ</searchLink>; VIB Center for Cancer Biology, KU Leuven Department of Oncology, Leuven, Belgium. colinda.scheele@kuleuven.be.<br /><searchLink fieldCode="AU" term="%22van+Rheenen+J%22">van Rheenen J</searchLink>; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. j.v.rheenen@nki.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2025 Jan; Vol. 637 (8044), pp. 195-204. <i>Date of Electronic Publication: </i>2024 Dec 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39633046 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41586-024-08276-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 195 Titles: – TitleFull: The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bornes L – PersonEntity: Name: NameFull: van Winden LJ – PersonEntity: Name: NameFull: Geurts VCM – PersonEntity: Name: NameFull: de Bruijn B – PersonEntity: Name: NameFull: Azarang L – PersonEntity: Name: NameFull: Lanfermeijer M – PersonEntity: Name: NameFull: Caruso M – PersonEntity: Name: NameFull: Proost N – PersonEntity: Name: NameFull: Boeije M – PersonEntity: Name: NameFull: Lohuis JO – PersonEntity: Name: NameFull: Belthier G – PersonEntity: Name: NameFull: Noguera Delgado E – PersonEntity: Name: NameFull: de Gruil N – PersonEntity: Name: NameFull: Kroep JR – PersonEntity: Name: NameFull: van de Ven M – PersonEntity: Name: NameFull: Menezes R – PersonEntity: Name: NameFull: Wesseling J – PersonEntity: Name: NameFull: Kok M – PersonEntity: Name: NameFull: Linn S – PersonEntity: Name: NameFull: Broeks A – PersonEntity: Name: NameFull: van Rossum HH – PersonEntity: Name: NameFull: Scheele CLGJ – PersonEntity: Name: NameFull: van Rheenen J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-4687 Numbering: – Type: volume Value: 637 – Type: issue Value: 8044 Titles: – TitleFull: Nature Type: main |
| ResultId | 1 |